Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 60 (-3.2%)Axles India₹ 525 (6.1%)Bira ₹ 108 (0%)CIAL ₹ 438 (0%)CSK ₹ 268 (3.9%)ESDS Software₹ 448 (0.7%)Garuda Aerospace₹ 485 (0%)GFCL EV₹ 42 (0%)Hella Infra₹ 110000 (-2.2%)Hero Fincorp₹ 1075 (2.4%)HPX India₹ 28 (7.7%)Incred Holdings₹ 152 (2.7%)India Carbon₹ 895 (0%)Indian Potash₹ 2850 (3.6%)Inox Clean₹ 725 (-8.8%)Insolare Energy₹ 185 (0%)Matrix Gas₹ 16 (0%)Motilal Oswal₹ 12.95 (12.6%)MSEI ₹ 6.25 (-3.8%)NCDEX ₹ 398 (-1.7%)NeRL ₹ 58 (0%)NSE ₹ 1965 (3.7%)Onix Renewable₹ 66 (13.8%)Orbis Financial₹ 408 (0.7%)OYO ₹ 24 (0%)Pharmeasy ₹ 6.25 (-3.8%)Polymatech Electronics₹ 62 (-3.1%)RRP S4E₹ 168 (0%)SBI Mutual₹ 775 (0%)Ticker Ltd₹ 32 (0%)Zepto ₹ 49 (-9.3%)

15 Days Price Change

Sunrest Lifescience IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2017 Industry: Trading Listed Page

Profile
Issue Size --
Profile
Price Range 84  to  84 per share
Profile
Min Investment ₹84
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Sunrest Lifescience Ltd is a dynamic and innovative company dedicated to the development and production of cutting-edge pharmaceutical and healthcare solutions. With a commitment to improving global health and well-being, Sunrest specializes in the research, formulation, and distribution of a wide range of pharmaceutical products, including generic and specialty medicines. Driven by a passion for quality and a focus on customer satisfaction, Sunrest Lifescience maintains the highest standards in manufacturing and compliance with industry regulations. The company's experienced team of scientists and professionals work tirelessly to deliver safe, effective, and affordable healthcare solutions to a diverse global market. Incorporating advanced technology and a strong commitment to research and development, Sunrest Lifescience is at the forefront of the pharmaceutical industry, ensuring access to life-changing medicines for people worldwide. Read More

Basic Info

Face Value 10 per share

Price 84  to  84 per share

P/E (x) 17.9

Sales( Cr.) 33

PAT( Cr.) 2

EPS 4.7

Draft Prospectus

Exchange NSE-SME

Promoter

Company Promoters

Mr. Nikhilkumar Y Thakkar Mr. Amitbhai Shambhulal Thakkar Mr. Bhagyesh Kiritbhai Parekh Mr. Bharatkumar V Thakkar.

Pre Issue Share Holding 100%

Post Issue Share Holding 78.96%

Listing Details:

Listing Price: 74.959641255605

Listing Gain: -12.06%

Current Price: 36.1

Gain On Issue: 36.1 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Nov 07, 2023
Closing Date Nov 09, 2023
Allotment Nov 10, 2023
Refund Nov 13, 2023
Delivery of Shares Nov 13, 2023
Listing Date Nov 14, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 134,400
Retail (Max) 1 1600 134,400
S-HNI (Min) 2 3200 268,800
S-HNI (Max) 7 11200 940,800
B-HNI (Min) 8 12800 1,075,200

Objective of the Issue

1. Meeting Working Capital Requirements 2. General Corporate Purpose 3. Meeting Public Issue Expenses

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 645600 18832152 29.2x
Retail 645600 42441744 65.7x
EMP 0 0 0x
Total 1291200 62674848 48.5x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Sunrest Lifescience Profit & Loss

#(Fig in Cr.) Mar 2025 TTM
Net Sales 33
Other Income 0
Total Income 33
Total Expenditure 30
Operating Profit 3
Interest 0
Depreciation 0
Exceptional Income / Expenses 0
Profit Before Tax 3
Provision for Tax 1
Profit After Tax 2
Adjustments -0
Profit After Adjustments 2
Adjusted Earnings Per Share 4.7

Sunrest Lifescience Balance Sheet

#(Fig in Cr.) Mar 2025
Shareholder's Funds 16
Minority's Interest 5
Borrowings 6
Other Non-Current Liabilities -0
Total Current Liabilities 31
Total Liabilities 58
Fixed Assets 4
Other Non-Current Assets 0
Total Current Assets 54
Total Assets 58

Sunrest Lifescience Cash Flow

#(Fig in Cr.) Mar 2025
Opening Cash & Cash Equivalents 0
Cash Flow from Operating Activities 3
Cash Flow from Investing Activities -1
Cash Flow from Financing Activities -0
Net Cash Inflow / Outflow 1
Closing Cash & Cash Equivalent 2

Sunrest Lifescience Ratios

# Mar 2025
Earnings Per Share (Rs) 4.67
CEPS(Rs) 4.91
DPS(Rs) 0
Book NAV/Share(Rs) 38.01
Core EBITDA Margin(%) 9.04
EBIT Margin(%) 8.77
Pre Tax Margin(%) 7.85
PAT Margin (%) 6.02
Cash Profit Margin (%) 6.3
ROA(%) 3.45
ROE(%) 12.33
ROCE(%) 10.33
Receivable days 397.25
Inventory Days 105.13
Payable days 417.13
PER(x) 11.5
Price/Book(x) 1.26
Dividend Yield(%) 0
EV/Net Sales(x) 1
EV/Core EBITDA(x) 11.04
Net Sales Growth(%) 0
EBIT Growth(%) 0
PAT Growth(%) 0
EPS Growth(%) 0
Debt/Equity(x) 0.74
Current Ratio(x) 1.73
Quick Ratio(x) 1.42
Interest Cover(x) 9.58
Total Debt/Mcap(x) 0.52

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -26% NA% NA% NA%
ROE Average 12% 12% 12% 12%
ROCE Average 10% 10% 10% 10%

Company Contact Information

Sunrest Lifescience Ltd.

6th Floor 608, West Gate, D - Block Nr. Brooklin Tower Nr. Y M C A Club Nr. S. G. Highway, Makarba

IPO Lead Manager(s)

Sunrest Lifescience Ltd.

Mark Corporate Advisors Pvt Ltd.

Registrar Info

Sunrest Lifescience Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!